Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia

gene2drug.com Life Science Industry Market Research

Life Science Industry Market Researchgene2drug.com
Why We’re Here
• Economic landscape
• Report scope
• Being a sponsor
2

Life Science Industry Market Researchgene2drug.com3
Your Feedback
(Type questions in the box on the side of your screen)

About BioInformatics LLC
4
§ A full-service market research
firm since 1994:
•  Published and syndicated
reports
•  Consulting and strategy
development
•  Expert interviews
•  Focus groups
•  Surveys
•  RateMyProduct™

§ Conducting market
research exclusively on
scientific markets:
• Lab products
• Analytical
instrumentation
• Biotechnology research
& bioprocessing
• Drug discovery &
development
• Molecular diagnostics
5
manufacturing & material science
chemical, food & beverage
environmental testing
clinical diagnostics
pharmaceutical agriculture biotech
laboratory products
life sciences

6
Project team includes scientists,
statisticians and business analysts.
Instant access to a 74,000+
member expert scientific panel.
An Overview of Your Epigenetic Research
© 2009 BioInformatics, LLC www.gene2drug.com 3-17
* Totals are based on number of times an item was selected.
* Percentages are based on number of respondents.
68%
57%
55%
47%
23%
20%
14%
10%
10%
5%
0% 10% 20% 30% 40% 50% 60% 70% 80%
Gene regulation
Disease mechanisms
Biomarkers
Basic biology of epigenetics
Therapeutic targets
Stem cells
Genomic imprinting
Transgenerational epigenetic
inheritance
Tissue repair/regeneration
X chromosome inactivation
Respondents 200
Gene regulation 135
Disease mechanisms 115
Biomarkers 110
Basic biology of epigenetics 94
Therapeutic targets 46
Stem cells 41
Genomic imprinting 27
Transgenerational epigenetic
inheritance 21
X chromosome inactivation 10
Question 9*
(check all that apply)
Conduct market research for major
suppliers in the industry.

Introduction
Robin Rothrock, Ph.D.
Director of Publications
7

Overview of the
Economic Landscape

United States
§ Sequester
§ Uncertainty regarding
healthcare reform
§ Changes in molecular
diagnostic tests coding and
reimbursement
§ Flat to declining
pharmaceutical R&D
budgets
10

Europe
§ Continued fiscal austerity
§ Changes in healthcare
institutions and funding
§ Funding of research is
complex and multilayered
§ Cross-border collaboration is
increasing
§ Leading institutions are taking
action to be competitive with
the U.S. in recruiting postdocs
from India and China
11

China
§ Government and
commercial investment:
>$260 billion over the next 5
years
•  500 universities
•  More than 150,000 life science
graduates per year
•  Four innovation clusters
•  7,500 life science companies
•  200 life science incubators
•  100 life science parks
12
§  “Sea turtles” return
§  Growth in pharmaceutical
market

A New Normal for Life Science Research
§ Slow global recovery
§ Unfavorable research funding
§ ñ pricing pressure
§ Growth in Asian markets may be slowing
13

Report Scope

Objectives
§ Understand current sources of funding
§ Compare and contrast FY2013 (actual), and FY2014
(projected) average lab budgets
§ Estimate scientists’ budget for purchases and anticipated
purchases in instrumentation and consumables
§ Take the pulse of the life science community regarding
funding and the future of life science research
15

Framework
Secondary research
§ An extensive review of
relevant research councils,
funding agencies and private
funding sources
§ United States and Europe
Primary research
§ Quantitative survey
administered to life scientists
in the United States, Europe
and Asia
§ Have budget authority
§ Sample size ≅ 1,000
§ 75% academic/gov’t and
25% life science industry
16

Questionnaire
§ Funding & Budgets
•  Current sources of funding
•  Average lab budgets (2013 and
2014)
•  Average lab budgets for
instrumentation
•  Average lab budgets for
consumables
•  Percent budget allocation for
overhead and salaries
•  Laboratory headcount
§ Techniques
•  Current usage
•  Explore adoption of new
products/techniques in the next
12 months
•  Purchase of instrumentation
(actual in 2013 and expected in
2014)
•  Identify new and emerging
technologies
17

Customer Sentiment
18
Will my project
be funded
next year?

Product Categories
§ Instrumentation for…
•  Cell-based analysis (flow cytometers,
high content analyzers, all
microscopes, high throughput
screening and analysis systems, etc.)
•  Genome analysis (thermal cyclers,
real-time PCR instrumentation,
microarray instrumentation, NGS,
capillary electrophoresis, etc.)
•  Protein analysis (chromatography,
electrophoresis, mass spectrometry,
label-free detection, calorimetry,
NMR, CD, etc.)
§ Consumables
•  Cell-based analysis kits and reagents
(cell culture media and reagents,
antibodies, cell biology kits, etc.)
•  Genome analysis kits and reagents
(enzymes, kits, ladders, nucleic acid
purification and separation products,
oligonucleotides [primers, RNAi], etc.)
•  Protein purification and separation
kits and reagents (chromatography
media, electrophoresis matrices,
protein ladders, etc.)
•  General laboratory chemicals,
plasticware, glassware and
disposables
19

Cell-Based Techniques
§ Bacteria Culture
§ Cell-Based Assays
§ Confocal Microscopy
§ Eukaryotic Cell/Tissue Culture
§ Flow Cytometry
§ Fluorescence Microscopy
§ Gene Expression Analysis
§ High Content Screening
§ High-Throughput Screening
(HTS)
§ Immunohistochemistry
§ Light Microscopy
§ Stem Cell Culture/Analysis
20

Genomics Techniques
§ Classical End-Point PCR
§ Cloning/Molecular biology
Techniques
§ DNA/RNA Microarrays
§ Genotyping
§ Next Generation Sequencing
§ Real-Time PCR
§ RNAi (including siRNA, miRNA)
§ Sanger DNA Sequencing
§ Single Nucleotide Polymorphism
21

Protein Techniques
§  2-D Gel Electrophoresis
§  Calorimetry (including ITC, DSC)
§  Enzyme-linked Immunosorbent
Assay (ELISA)
§  Label-Free Detection/Analysis
(Including Biosensors, SPR, etc.)
§  Light Scattering (MALS, DLS)
§  Mass Spectrometry
§  Multiplex Bead Assays
§  Protein Purification & Separation
§  Protein Structural Analysis (NMR,
CD, etc.)
§  Western Blotting
22

Deliverable
23
UK, France,
Germany,
Spain, Italy,
Switzerland &
Scandinavia
China, India,
South Korea,
Singapore &
Japan

Why this report?

Share Gain/Share Protect Strategies
§ Where is the growth?
§ Funding trends?
§ Are researchers pitching their
grants to follow the money?
25

How You Can Use It
§ Check assumptions
§ Make decisions
§ Forecast revenues
§ Identify potential growth
26

Benefits of Being a Sponsor
27
Cost Control
Start-up Time
Expertise
Objectivity
Efficiency

Fees
28
$80,000-$100,00
Cost of sponsorship is $15,000

Questions?

Contact
Mary Follin
Marketing/Sales Manager
703.778.3080 x13
m.follin@gene2drug.com
30
Lab Budgets and
Sources of Funding in
2014
Multi-Sponsor Research
December 2013
CALL TODAY to BECOME
A SPONSOR!

Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia

Recomendados

Recomendados

Más contenido relacionado

Último

Último (20)

Destacado

Destacado (20)

Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia